According to the clinical course of the 195 pregnancies three groups were formed. a) Normal pregnancies: 137 pregnancies without Symptoms of risk. Only such pregnant women were included in this group for whom the history of menstruation, clinical progress and ultrasound diagnostic findings concerning the stage of pregnancy coincided. This group did not contain pregnant women having laborlike pains, hemorrhages, who were suspected to be diabetics (latent or manifest), having an incompatible Rh-constellation, or expecting twins. No young (5j 18 years of age) or late (^30 years) O-parae or late multiparae (^ 40 years) were in-cluded. All pregnancies terminated normally (37th to 43th), aÜ infants were of normal weight (between the lOth and the 90th percentile according to LUBCHENCO). b) Threatened pregnancy with successful outcome: 49 pregnant women had uterine hemorrhages in the period between the 6th and the 20th week of gestation, however, it was possible to discharge these pätients from the hospital after stationary treatment in a state of intact pregnancy. No pätients with other Symptoms of risk were accepted into this group (see above). c) Threatened pregnancies with unsuccessful outcome: 10 pregnant women hospitalized with uterine hemorrhages had an abortion. Pregnant women we could not categorize to any one of the above groups (such äs diabetics) \were not included in our investigation.
Method
• t
The blood samples were set aside for about 15 minutes at room temperature and then centrifuged at 3000 rpm for 5 minutes. Until the time of HPL determination (not later than 3 days after taking the sample) the samples were fronen at -20°C. All samples were examined twice at two different sensitivity regions, for evaluation we used the individual average values of each region showing the respectively higher accuracy of measureinent. In the radioimmunological determination procedure we followed LETCH-WORTH'S method [7] . Corresponding to the HPL content of the maternal serum in early pregnancy we used two different sensitivity regions, where the Standard sera for assay C covered the region from 0-0.5/ig/ml and the Standard sera for assay B covered the region from 0-1.5 /ig/ml. Assay A contained the Standard sera from 1.0-10.0 //g/ml. Sera with an HPL content above the region of assay B were additionally measured together with assay A. For assay C and B incubation time of the Standard sera and of the patient sera with the HPL antibody solution of the corresponding sensitivity region and the antigenantibody complex with labeled HPL was always one hour, whereas incubation time for assay A was thirty minutes. Separation of bound and of free HPL was carried out by precipitation with absolute ethanol, the radioactivity of the bound labeled HPL in the precipitate was measured in a well-type y-counter (Spectroscaler III A, PICKER Company). Measuring time was chosen in a way that the counts per minute of the samples containing 0.5, 1.5 or 10.0 /ig/ml amounted to at least 10,000 cpm. The HPL content of the sample to be examined was read off from the Standard curve previously drawn. We fixed the limits of the working scopes of assay B and assay C at 0.18 //g/ml applying the following procedure: From about 20 Standard curves we found the ranges with the highest marked rise and therefore with the best readability (Fig. 1) . The limit values, in which the rise of the assay B Standard curve was steeper than that of the assay C Standard curve were near 0.18//g/ml. We used the same procedure to fix the limit values between assay A and B, the value we obtained was 1.3//g/ml. As an outcome of this limitation the working scope of assay C went up to 0.18//g/ml, of assay B from 0.18 //g/ml to 1.3//g/ml and of assay A extended to beyond 1.3//g/ml. Out of the measured values from different sensitivity regions we always selected the value within the working scope of assay A, B or C. Whenever the measured values lay in different working scopes, we calculated the arithmetic mean. The lowest limit permitting to prove the existence of HPL by assay C is about 0.01 to 0.02//g/ml. A cross-reaction with HGH antibody-solution occurs in approximately 3-5% of 0.01 //g/ml [2] .
Statistical evaluation
The random samples resulting from the patients belonging to one of the three groups and from the weck of gestation were then arranged in an order, where medium, maximum and minimum values were determined [4] . The accuracy of the method depends on the degree o£ conformity between the determined ideal value and the arithmetic mean value from many determinations of one and the same sample. 20 repeat determinations of the HPL content of two control sera with ideal values of 0.8//g/ml respectively of 0.15/ig/ ml were carried out every time, one of the control tests was always run undisclosed alongside the routine determinations. a) Assay C: accuracy = 92,5% b) Assay B: accuracy = 95%
Precision
The precision of a method depends on the scatter of measured results around the arithmetic mean value of many determinations of one and the same sample. As an index we used the coefficient of Variation. 20 repeat determinations of the HPL content of two conttol sera were again carried out, of these control 
Clinical results
Fig . 2 shows the HPL values found in 254 serum samples from 137 women with normal pregnancy, and Fig. 3 shows 141 samples taken from 49 patients with threatened pregnancies with successful outcome for the period of the 6th to the 20th week of pregnancy. The two measuring ranges overlap to a considerable degree, however, from the 15th week of pregnancy onward the tnedian of normal pregnancy is noticeably higher than the median of threatened pregnancies with successful outcome. That means that greater HPL values are found more frequently in normal pregnancies than in threatened pregnancies with successful outcome; however, no conclusion concerning the condition of pregnancy can be drawn on the basis of a single value.
It is also striking that minimum values for normal pregnancies beginning with the ninth week are considerably higher than those for threatened pregnancies with successful outcome.
At this point we used the fourfold test formulated s described above. 1.5- sometimes impossible due to the composition of random samples since the number of cases below the minimum values for normal pregnancy is not sufficient for the application of the fourfold test. From the 13th to the 17th week of pregnancy and in the 20th week there are significant differences with a varying probability of error. Fig. 4 shows the values for patients who later had an abortion (threatened pregnancy with unsuccessful outcome). It is remarkable here that part of these values lie within the area which was measured also for threatened pregnancies with successful outcome.
Discussion
The HPL values measured in women with normal pregnancies coincide with the values published by NIVEN et al. [9] and MELCHERT [8] when a slightly modified technique is taken into account. Our findings, however, agree also with the values published by KELLER et al. [6] , although there are important methodological radio-immunological differences. Our values are lower than those obtained by JANISCH et al. [5] and by YLI-KORKALA [12] who applied different radio-immunological methods. Results show that the values in the serum of women with normal pregnancy and threatened pregnancies with successful outcome, overlap tp a large extent from the 6th to the 20th week of pregnancy. However, the median HPL values of the threatened pregnancy with successful outcome starting with the 15th week are markedly lower than those in normal pregnancies. These lower HPL values in threatened pregnancies with successful outcome, are possibly an indication of a beginning placental insufficiency. The frequency of dysmature children born at term is significantly higher in women with hemorrhages during early pregnancy than in women without hemorrhages [10] . On the other hand HPL values are supposed to be lower for dysmature infants during the second half of pregnancy [1] . Throughout the first half of gestation, threatened pregnancies with successful outcome often show lower HPL values than normal pregnancies. These differences are partly significant below or at the 5% level. HPL values of women with uterine hemorrhage who later have an abortion are low. Up to the 9th week of pregnancy a low or nonexistent '»HPL content does not allow any Statement concerning the further course of the pregnancy. The later the pregnancy the stronger is the prognostic indication of a low HPL value. Results however, have also shown, that a single HPL determination in a threatened pregnancy resulting in the ränge of threatened pregnancies with successful outcome does not allow the assumption that the pregnancy will remain intact. In this sense a continuous increase of HPL can only be used very cautiously.
Conclusions
1. One single HPL result within the scatter area for normal pregnancies or for threatened pregnancies with successful outcome is an indication that at the time of HPL determination the placental function was intact. The result of such a single HPL determination at best permits only a diagnostic Statement and not a prognostic one. On the other hand when one single HPL determination shows values below the scatter area for threatened pregnancies with successful outcome it can be stated that the placental function is out of order.
A careful prognostic Statement may be made only after repeated HPL determinations.
Continuously increasing HPL values in the scatter area for normal pregnancies or for threatened pregnancies with successful outcome indicate that the pregnancy may terminate without disturbance. No increase or decrease of HPL values indicates a less favorable prognosis. The later the pregnancy (for example 15th to 20th week of pregnancy) the more one will be inclined to draw the clinical consequence of terminating the pregnancy when the HPL values are markedly pathological. 3 . HPL values determined after the 9th week of pregnancy, lying considerably below the minimum values for threatened pregnancies with successful outcome, indicate that the fetus is either about to die or älreädy dead. 4. In the light öf our findings the diagnostic and prognostic importance of HPL values determined before the 9th week of pregnancy in cases of threatened pregnancy is doubtful.
Summary
To determine the purpose of the HPL area for normal pregnancies and for checking whether deviating HPL values are to be found in women with uterine hemorrhage during the first half of pregnancy a well-defined group of pregnant women was necessary. For this reason 411 blood samples were taken from the cubital vein in the 6th to the 20th week of pregnancy post menstruationem of 195 women who in the last 6 months of 1973 came to the prenatal care center or were admitted to the hospital. According to the clinical course of the 195 pregnancies three groups were formed: Normal pregnancies, threatened pregnancies with successful outcome, threatened pregnancies with unsuccessful outcome. The women with threatened pregnancies had uterine hemorrhages in the period between the 6th and the 20th week of gestation. Women with other Symptoms of risk were not admitted to any one of the groups. All samples were examined in the sensitivity region assay C (Standard sera 0-0.5 ^ug/ml) and assay B (0-1.5 /Jg/ml). In the radio-immunological determination we proceeded according to LETCHWORTH et al. After measuring the rise of the Standard curves the limits of the working scope were fixed at 0.18 ^ag/ml between assay B (Fig. 1) and assay C and at 1.3//g/ml between assay B and assay A. To check the method we calculäted the 'äccüracy of assay C with 92.5% and of assay B with 95%. The coefficient of Variation (precision) of assay C and B amounted to 3% for each one. Fig. 2 shows the HPL values in 254 serum samples from 137 women with normal pregnancies, Fig. 3 those of 49 women with threatened pregnancies with successful outcome in 141 samples.
The t wo scatter areas overlap to a considerable extent; beginning in the 15th weck of pregnancy in normal pregnancies the median lies considerably above the median of threatened pregnancy with successful outcome. Minimum values for normal pregnancies from the 9th week onward are considerably higher than the values for threatened pregnancies with successful outcome (Tab. I). Values for patients with uterine hemorrhage later who had an abortion are partly within the ränge for threatened pregnancies with successful outcome (Fig. 4) . The results permit to draw the following most important conclusions:
Keywords: Abortion, early pregnancy, HPL. normales se situe a partir de la 15eme semaine nettement au-dessus de la m£dianp des grossesses difficiles a issue positive. Les valeurs minimales des grossesses normales ä partir de la 9eme semaine se situent de fa$on significative au-dessus des valeurs minimales des grossesses difficiles bien termin^es (Tab. I). Les valeurs des patientes avec hemorragies uterines et qui ont eu un avortement par la suite se situent en partie dans la zone des grossesses difficiles avec bonne issue (Fig. 4) 
